38.50p-1.30 (-3.27%)20 Jan 2022, 08:01
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

E-Therapeutics PLC Fundamentals

Company NameE-Therapeutics PLCLast Updated2022-01-20
Shares in Issue514.571 mMarket Cap£198.10 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.0258Cash Equity Ratio0.9576
Quick Ratio37.4078Current Ratio39.59
Price To Book Value6.2073ROCE0

E-Therapeutics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

E-Therapeutics PLC Company Financials

Tangible Assets£80,000.00£93,000.00£42,000.00
Intangible Assets£82,000.00£110,000.00£119,000.00
Total Fixed Assets£162,000.00£203,000.00£161,000.00
Cash & Equivalents£13.03 m£3.84 m£5.90 m
Other Assets000
Total Assets£14.31 m£4.79 m£7.51 m
Creditors within 1 year£427,000.00£261,000.00£707,000.00
Creditors after 1 year0£23,000.000
Other Liabilities000
Total Liabilities£427,000.00£284,000.00£707,000.00
Net assets£13.88 m£4.50 m£6.80 m
Called up share capital£421,000.00£269,000.00£269,000.00
Share Premium£77.67 m£65.18 m£65.17 m
Profit / Loss-£4.47 m-£2.87 m-£5.08 m
Other Equity£13.88 m£4.50 m£6.80 m
Preference & Minorities000
Total Capital Employed£13.88 m£4.50 m£6.80 m
Debt Ratio0£0.010
Assets / Equity1.02581.02581.0258
Cash / Equity0.95760.95760.9576
Cash Flow202120202019
Cash from operating activities-£3.36 m-£2.03 m-£3.70 m
Cashflow before financing£9.24 m-£2.06 m-£3.69 m
Increase in Cash£9.19 m-£2.06 m-£1.19 m
Cost of sales000
Gross Profit£317,000.00£456,000.00£44,000.00
Operating Profit-£4.49 m-£2.89 m-£5.11 m
Pre-Tax profit-£4.47 m-£2.87 m-£5.08 m

E-Therapeutics PLC Company Background

Activitiese-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease.
Latest Interim Date26 Oct 2021
Latest Fiscal Year End Date13 May 2021

E-Therapeutics PLC Directors

2020-02-11Mr. Iain Gladstone RossNon-Executive Director,Chairman
2020-02-11Ms. Christine Helen SodenNon-Executive Director
2011-08-09Mr. Johnny Mark CordinerExecutive Director,Finance and Commercial Director
2022-01-13Professor Trevor Mervyn Jones CBENon-Executive Director,Chairman
2021-05-21Mr. Michael Anthony BrethertonNon-Executive Director,Interim Chief Financial Officer
2015-05-12Professor Oliver Francis Wintour JamesNon-Executive Director,Chairman
2017-05-08Professor Malcolm Philip YoungExecutive Director,Chief Executive Officer
2011-08-09Dr. Royston Frederick DruckerExecutive Director,Chief Medical Officer
2018-04-04Mr. Bradley Richard HoyNon-Executive Director
2018-04-04Mr. Sean Torquil Nicolson Executive Director,Company Secretary
2018-04-04Mr. Stephen Raymond SelfExecutive Director,Development Director
2014-04-07Mr. Daniel ElgerExecutive Director,Chief Financial Officer
2015-10-29Dr. Rajesh ChopraNon-Executive Director
2021-10-26Mr. Ahmad Ali Mortazavi Executive Director,Chief Executive Officer
2021-05-21Mr. Steven MedlicottExecutive Director,Finance Director and Interim COO
2020-02-11Dr. Raymond John BarlowExecutive Director,Chief Executive Officer

E-Therapeutics PLC Contact Details

Company Namee-Therapeutics PLC
Address17 Blenheim Office Park, Long Hanborough, OX29 8LN
Telephone+44 1993880000

E-Therapeutics PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
SolicitorStephenson Harwood
Phone+44 2073294422
Fax+44 2073297100
StockbrokerNumis Securities Limited
Phone+44 2072601000
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
Phone+44 2079363000
SolicitorBond Dickinson
Phone+44 3454150000
Fax+44 3454155256
Financial PR AdviserInstinctif Partners
Phone+44 2074572020
Fax+44 2078667900
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132
BankBank of Scotland